Associated Papers
Lentiviral Gene Therapy for Severe Leukocyte Adhesion Deficiency Type 1.
Booth C et al.
The New England Journal of Medicine, 2025
A novel ITGB2 variant in a patient with severe recurrent pyoderma gangrenosum-like lesions and underlying leukocyte adhesion deficiency type I: case report and literature review.
Norouzi-Barough L et al.
Archives of Dermatological Research, 2025
Contribution of next generation sequencing to the diagnosis of inborn errors of immunity in a pediatric cohort.
Godinez-Zamora GF et al.
Frontiers in Immunology, 2025
Sweet syndrome associated with moderate leukocyte adhesion deficiency type I: a case report and review of the literature.
Saito Y et al.
Frontiers in Immunology, 2024
Rare and heterogeneous manifestations of leucocyte adhesion deficiency type 1: report of two cases with diagnostic dilemmas and novel ITGB2 mutation.
Anis S et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology, 2023
Hematologically important mutations: Leukocyte adhesion deficiency (second update).
Roos D et al.
Blood Cells, Molecules & Diseases, 2023
Clinical manifestations and expression of CD18 to guide the diagnosis of leukocyte adhesion deficiency type 1: Mexico experience.
Fuentes-Lara EI et al.
Allergologia Et Immunopathologia, 2023
Targeted Gene Sanger Sequencing Should Remain the First-Tier Genetic Test for Children Suspected to Have the Five Common X-Linked Inborn Errors of Immunity.
Chan KW et al.
Frontiers in Immunology, 2022
Clinical and laboratory findings in patients with leukocyte adhesion deficiency type I: A multicenter study in Turkey.
Yaz I et al.
Clinical and Experimental Immunology, 2021
Primary immunodeficiency-related genes in neonatal intensive care unit patients with various genetic immune abnormalities: a multicentre study in China.
Zhu T et al.
Clinical & Translational Immunology, 2021
Leukocyte Adhesion Deficiency Type 1 Due to Novel ITGB2 Mutation.
Harvey S et al.
Irish Medical Journal, 2020
β2 Integrin Gene (ITGB2) mutation spectra in Pakistani families with leukocyte adhesion deficiency type 1 (LAD1).
Nawaz Tipu H et al.
Immunobiology, 2020
Clinical and Genetic Spectrum of a Large Cohort of Patients With Leukocyte Adhesion Deficiency Type 1 and 3: A Multicentric Study From India.
Kambli PM et al.
Frontiers in Immunology, 2020
Clinical utility in infants with suspected monogenic conditions through next-generation sequencing.
Hong S et al.
Molecular Genetics & Genomic Medicine, 2019
Report of a Chinese Cohort with Leukocyte Adhesion Deficiency-I and Four Novel Mutations.
Sun B et al.
Journal of Clinical Immunology, 2019
Novel Mutations in the β2 Integrin Gene (ITGB2) in a Moderate Leukocyte Adhesion Defect type 1 Patient.
Hu J et al.
Archives of Iranian Medicine, 2018
Successful adjunctive immunoglobulin treatment in patients affected by leukocyte adhesion deficiency type 1 (LAD-1).
Yamazaki-Nakashimada M et al.
Immunologic Research, 2015
Molecular characterization of leukocyte adhesion deficiency-I in Indian patients: identification of 9 novel mutations.
Madkaikar M et al.
Blood Cells, Molecules & Diseases, 2015
Hematologically important mutations: leukocyte adhesion deficiency (first update).
van de Vijver E et al.
Blood Cells, Molecules & Diseases, 2012
Neutrophil function and molecular analysis in severe leukocyte adhesion deficiency type I without separation delay of the umbilical cord.
Tsai YC et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology, 2008
A novel leukocyte adhesion deficiency caused by expressed but nonfunctional beta2 integrins Mac-1 and LFA-1.
Hogg N et al.
The Journal of Clinical Investigation, 1999